Molnupiravir is an experimental medication that has garnered attention as a potential option for treating COVID-19. It works by generating errors into the disease's RNA material, thus stopping its spread within the patient . While preliminary assessments showed significant results in reducing the time of illness and the chance of hospitalization ,